Detecting familial hypercholesterolaemia in the community: Impact of a telephone call from a chemical pathologist to the requesting general practitioner

Atherosclerosis

Volumn 234, Issue 2, 2014, Pages 469-472

  Bell, Damon A ^a,b,c   Hooper, Amanda J ^a,b,d   Edwards, Glenn ^c   Southwell, Lynda ^d   Pang, Jing ^d   van Bockxmeer, Frank M ^b,d   Watts, Gerald F ^a,b   Burnett, John R ^a,b  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c Department of Clinical Biochemistry St John of God Pathology ^*  (Australia)

^d UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Community laboratory; Detection; Familial hypercholesterolaemia; Opportunistic screening

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FOLLOW UP; GENE MUTATION; GENERAL PRACTITIONER; GENETIC SCREENING; HIGH RISK PATIENT; HUMAN; INHERITANCE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; PATHOLOGIST; PATIENT REFERRAL; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; SCREENING; TELEMEDICINE; ATTITUDE TO HEALTH; AUSTRALIA; BLOOD; CASE CONTROL STUDY; COMMUNITY CARE; GENETIC PREDISPOSITION; GENETICS; HEALTH PERSONNEL ATTITUDE; HYPERLIPOPROTEINEMIA TYPE II; INTERDISCIPLINARY COMMUNICATION; MIDDLE AGED; PATHOLOGY; PHENOTYPE; PREDICTIVE VALUE; RISK ASSESSMENT; RISK FACTOR; TELEPHONE; UPREGULATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ATTITUDE OF HEALTH PERSONNEL; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; COMMUNITY HEALTH SERVICES; FEMALE; GENERAL PRACTITIONERS; GENETIC PREDISPOSITION TO DISEASE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; INTERDISCIPLINARY COMMUNICATION; MALE; MIDDLE AGED; PATHOLOGY, CLINICAL; PHENOTYPE; PREDICTIVE VALUE OF TESTS; REFERRAL AND CONSULTATION; RISK ASSESSMENT; RISK FACTORS; TELEPHONE; UP-REGULATION; WESTERN AUSTRALIA; YOUNG ADULT;

EID: 84900870893     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2014.04.002     Document Type: Article

References (23)

1. Watts G.F., Sullivan D.R., Poplawski N., et al. Familial hypercholesterolaemia: a model of care for Australasia. Atheroscler Suppl 2011, 12(2):221-231.
2. Nordestgaard B.G., Chapman M.J., Humphries S.E., et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 2013, 34(45):3478-3490.
3. Bender R., Bell D.A., Hooper A.J., et al. Screening for familial hypercholesterolaemia. Pathology 2012, 44(2):122-128.
4. Versmissen J., Oosterveer D.M., Yazdanpanah M., et al. Efficacy of statins in familial hypercholesterolaemia: a long term cohort study. Brit Med J 2008, 337:a2423.
5. Neil A., Cooper J., Betteridge J., et al. Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study. Eur Heart J 2008, 29(21):2625-2633.
6. Bell D.A., Hooper A.J., Bender R., et al. Opportunistic screening for familial hypercholesterolaemia via a community laboratory. Ann Clin Biochem 2012, 49(Pt 6):534-537.
7. Watts G.F., Sullivan D.R., van Bockxmeer F.M., et al. Amodel of care for familial hypercholesterolaemia: key role for clinical biochemistry. Clin Biochem Rev 2012, 33(1):25-31.
8. Bell D.A., Bender R., Hooper A.J., et al. Impact of interpretative commenting on lipid profiles in people at high risk of familial hypercholesterolaemia. Clin Chim Acta 2013, 422:21-25.
9. Damgaard D., Larsen M.L., Nissen P.H., et al. The relationship of molecular genetic to clinical diagnosis of familial hypercholesterolemia in a Danish population. Atherosclerosis 2005, 180(1):155-160.
10. Civeira F., Ros E., Jarauta E., et al. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia. Am J Cardiol 2008, 102(9):1187-1193.
11. Hooper A.J., Nguyen L.T., Burnett J.R., et al. Genetic analysis of familial hypercholesterolaemia in Western Australia. Atherosclerosis 2012, 224(2):430-434.
12. Benn M., Watts G.F., Tybjaerg-Hansen A., Nordestgaard B.G. Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication. JClin Endocrinol Metab 2012, 97(11):3956-3964.
13. Muir L.A., George P.M., Laurie A.D., Reid N., Whitehead L. Preventing cardiovascular disease: a review of the effectiveness of identifying the people with familial hypercholesterolaemia in New Zealand. NZ Med J 2010, 123(1326):97-102.
14. Marks D., Wonderling D., Thorogood M., Lambert H., Humphries S.E., Neil H.A. Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia. Brit Med J 2002, 324(7349):1303.
15. NICE Clinical guideline 71: identification and management of familial hypercholesterolaemia 2008, http://www.nice.org.uk/nicemedia/pdf/CG071NICEGuideline.pdf.
16. Descamps O.S., Tenoutasse S., Stephenne X., et al. Management of familial hypercholesterolemia in children and young adults: consensus paper developed by a panel of lipidologists, cardiologists, paediatricians, nutritionists, gastroenterologists, general practitioners and a patient organization. Atherosclerosis 2011, 218(2):272-280.
17. Nherera L., Marks D., Minhas R., Thorogood M., Humphries S.E. Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies. Heart 2011, 97(14):1175-1181.
18. Gray J., Jaiyeola A., Whiting M., Modell M., Wierzbicki A.S. Identifying patients with familial hypercholesterolaemia in primary care: an informatics-based approach in one primary care centre. Heart 2008, 94(6):754-758.
19. Bell D.A., Garton-Smith J., Vickery A., et al. Familial hypercholesterolaemia in primary care: knowledge and practices among general practitioners in Western Australia. Heart Lung Circ 2013, [In Press]. 10.1016/j.hlc.2013.08.005.
20. Foody J.M. Familial hypercholesterolemia: an under-recognized but significant concern in cardiology practice. Clin Cardiol 2014, 37(2):119-125.
21. Bell D.A., Watts G.F., Foody J.M. Familial hypercholesterolemia: an under-recognized but significant concern in cardiology practice. Clin Cardiol 2013, [In Press]. 10.1002/clc.22257.
22. Morris J.K., Wald D.S., Wald N.J. The evaluation of cascade testing for familial hypercholesterolemia. Am J Med Genet A 2012, 158A(1):78-84.
23. Hovingh G.K., Davidson M.H., Kastelein J.J., O'Connor A.M. Diagnosis and treatment of familial hypercholesterolaemia. Eur Heart J 2013, 34(13):962-971.